KLP Kapitalforvaltning AS Purchases 8,600 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Key Points

• KLP Kapitalforvaltning AS significantly increased its stake in USANA Health Sciences, acquiring 8,600 additional shares for a total ownership of 10,900 shares, representing a growth of 373.9%.
• USANA Health Sciences reported quarterly earnings of $0.74 EPS, which exceeded analysts' expectations of $0.54, along with revenue of $235.85 million surpassing the consensus estimate.
• Insider trading reports showed that COO Walter Noot and other insiders sold a total of 15,528 shares of USANA stock recently, amounting to $466,513.

KLP Kapitalforvaltning AS raised its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 373.9% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,900 shares of the company's stock after buying an additional 8,600 shares during the quarter. KLP Kapitalforvaltning AS owned 0.06% of USANA Health Sciences worth $294,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its holdings in shares of USANA Health Sciences by 542.5% during the 1st quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after purchasing an additional 971 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of USANA Health Sciences by 8,141.2% during the 1st quarter. Parallel Advisors LLC now owns 1,401 shares of the company's stock worth $38,000 after purchasing an additional 1,384 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in shares of USANA Health Sciences by 635.5% during the 4th quarter. Public Employees Retirement System of Ohio now owns 5,075 shares of the company's stock worth $182,000 after purchasing an additional 4,385 shares in the last quarter. Massachusetts Financial Services Co. MA acquired a new stake in shares of USANA Health Sciences during the 4th quarter worth $206,000. Finally, GAMMA Investing LLC grew its holdings in shares of USANA Health Sciences by 49,082.4% during the 1st quarter. GAMMA Investing LLC now owns 8,361 shares of the company's stock worth $225,000 after purchasing an additional 8,344 shares in the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Price Performance

NYSE:USNA traded up $0.38 during trading hours on Monday, hitting $29.24. The company's stock had a trading volume of 12,964 shares, compared to its average volume of 183,094. The stock has a fifty day simple moving average of $30.90 and a 200-day simple moving average of $29.88. The company has a market capitalization of $544.54 million, a P/E ratio of 16.19, a PEG ratio of 0.92 and a beta of 0.61. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $41.83.

USANA Health Sciences (NYSE:USNA - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.20. The business had revenue of $235.85 million for the quarter, compared to analyst estimates of $225.20 million. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. On average, equities analysts predict that USANA Health Sciences, Inc. will post 2.45 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Wall Street Zen raised USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of the stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Insiders have sold 14,854 shares of company stock valued at $446,415 over the last ninety days. 0.63% of the stock is owned by corporate insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.